Navigation Links
Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting

SAN DIEGO, April 09, 2007 /PRNewswire/ -- Nereus Pharmaceuticals, Inc., a pioneer in drug discovery and development from marine microbial sources, and its collaborators will present clinical and preclinical study results involving its cancer drug candidates at the American Association for Cancer Research Annual Meeting in Los Angeles April 14-18. Four posters and two minisymposia will highlight the novel mechanisms and anti-tumor activity in several tumor models for three Nereus compounds: the small molecule proteasome inhibitor NPI-0052, the tumor vascular disrupting agent (VDA) NPI-2358, and a new preclinical candidate NPI-1387, a highly selective, small molecule IKK modulator. Nereus will also present preliminary data from its Phase I dose escalation trial of NPI-2358 in patients with solid tumors and lymphoma.

In addition to the Company's single agent studies, Nereus collaborators from the University of Texas M.D. Anderson Cancer Center will describe research demonstrating markedly enhanced potency and apoptosis in human leukemia cells treated with NPI-0052 and various histone deacetylase (HDAC) inhibitors.

Nereus researchers and collaborators will make the following presentations at AACR:

Sunday, April 15, 2007

#1445: Sensitization of B-NHL resistant tumor cells overexpressing Bcl-xL to TRAIL-induced apoptosis by the novel proteasome inhibitor Salinosporamide A (NPI-0052)

Eriko Suzuki, Michael Palladino, Genhong Chen, Benjamin Bonavida. David Geffen School of Medicine at UCLA, Los Angeles, CA, Nereus Pharmaceuticals, San Diego, CA

#1453: Rituximab-mediated sensitization of resistant B-NHL cell lines to the proteasome inhibitor NPI-0052-induced apoptosis: pivotal role of PTEN induction and inhibition of Bcl-xL

Eriko Suzuki, Michael Palladino, Benjamin Bonavida. David Geffen School of Medicine at UCLA, Los Angeles, CA, Nereus Pharmaceuticals, San Diego, CA


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:5/4/2015)... 4, 2015 PAREXEL International Corporation (NASDAQ: PRXL ... UBS Healthcare Conference on Monday, May 18, 2015, in New ... Chief Financial Officer will be making a presentation on PAREXEL ... A live webcast of the presentation will be available through ... in the Upcoming Events portion of the main page, and ...
(Date:5/4/2015)... Pa. , May 4, 2015  Makindus, Inc. ... today that the European Medicines Agency (EMA) has granted ... the treatment of Stargardt,s Disease. "We are ... MI-100 to treat Stargardt,s disease in place for ... development program in the United States ...
(Date:5/4/2015)... BUFFALO, N.Y. , May 4, 2015 /PRNewswire/ ... Stephanie Englert , PharmD, has completed preliminary analysis ... Disorder and Schizophrenia. Resources from Clinical Support Services, ... Medication Reviews (CMR) with patients currently taking psychiatric ... events. The research found that 93% of patients ...
Breaking Medicine Technology:PAREXEL International to Present at UBS Healthcare Conference 2European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 2Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 3
(Date:5/4/2015)... Takeda Pharmaceuticals Corp. has agreed to ... of Actos lawsuits ( http://www.theactoslawsuitcenter.com/ ) that allege ... a patient will develop bladder cancer. According to ... those eligible for the Actos settlement accept its terms, ... currently pending in courts around the country, including thousands ...
(Date:5/4/2015)... “ LiveSchool ” was featured on ... a look at the latest and coolest applications on ... the host of AppWatch and technology expert, conducted the ... allows teachers to reward students with good behavior. , ... in the classroom. And the good people at ...
(Date:5/4/2015)... 04, 2015 Baptist Medical Center ... Association’s Get With The Guidelines®-Stroke Gold Plus Quality ... Roll. The award recognizes the hospital’s commitment and ... most appropriate treatment according to nationally recognized, research-based ... To receive the Gold Plus Quality Achievement Award, ...
(Date:5/4/2015)... NY (PRWEB) May 04, 2015 Ticket Down ... 2015 International Champions Cup (ICC) . While the World ... and is held every four years, the International Champions Cup ... the tournament saw the all-time attendance record for soccer in ... from the Big House at the University of Michigan. This ...
(Date:5/4/2015)... 2015 Ticket Down is a reputable source ... Arena in Columbia, South Carolina. Fans of Paul ... “Out There” tour which originally kicked off in 2013. The ... America and the legendary performer recently announced that he would ... Arena on June 21st, in Charlottesville, VA at John Paul ...
Breaking Medicine News(10 mins):Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2
... turns off genes that keep tumors from forming, research shows ... insight into how a carcinogen in tobacco known as NNK ... at National Cheng Kung University in Taiwan report that NNK ... the nucleus of cells. In turn, DNMT1 turns off genes ...
... Obese patients can take steps to minimize risk, experts say ... of excess weight are well-known, such as heart disease, high ... obese patient is also a challenge for an anesthesiologist to ... our patients are obese," said Dr. Kumar Belani, a professor ...
... similar to MS in humans, findings show , TUESDAY, ... gene called ZFP191 causes central nervous system myelination problems ... humans with multiple sclerosis, new research has found. , ... and destroys the myelin sheath that insulates and protects ...
... ... nation’s leader in the fight against the disease ALS (amyotrophic laterals sclerosis) announced today ... , ... Calif. (Vocus) January 19, 2010 -- The ALS Association , the nation’s ...
... 11 A.M. , Justin Herman Plaza , ... , www.walkforlifewc.c o m , Speakers and organizers are ... A woman who walked away from her job as a clinic director ... intent on exposing abuses in the abortion industry will speak at the 6th Annual ...
... PORT-AU-PRINCE, Haiti , Jan. 19 One ... the challenges of delivering aid in the aftermath of the ... , Although aid is beginning to get through, the impact ... logistical challenges combined with a destroyed office and warehouse and ...
Cached Medicine News:Health News:Excess Weight Poses Anesthesia Challenge 2Health News:Excess Weight Poses Anesthesia Challenge 3Health News:Gordon S. LaVigne Appointed ALS Association Chief Development and Communications Officer , 2Health News:Gordon S. LaVigne Appointed ALS Association Chief Development and Communications Officer , 3Health News:6th Annual Walk for Life West Coast Saturday, January 23, 2010 2Health News:Haiti Earthquake: One Week Later, Aid Agencies Facing Challenges 2
300XL System, English (U.K. cord), 100-240 VAC....
Micro-mini fiber optic light....
Micro-mini fiber optic light....
The MC-3 allows for simultaneous use of two lamps, with an additional built-in spare....
Medicine Products: